Novartis news in 2026: 30 dated events
The latest Novartis event on this page is dated Sep 29, 2026. biospace.com reported: 3 steps for taking on Novartis in radiopharma: Curium up first.
PublicPharmaceutical Manufacturing10,000+ employeesnovartis.comLinkedIn
- Dated events
- 30
- Last 90 days
- 22
- Latest
- Sep 29, 2026
News · latest 10
Latest Novartis news
Showing 10 of 30 dated events. The Signal API returns all of them.
Get them with one API call- 3 steps for taking on Novartis in radiopharma: Curium up firstNovartis generated $1.7 billion in revenue from its radioligand therapies Lutathera and Pluvicto in the first half of the year.
- Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)Novartis's drug Cosentyx® (secukinumab) received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), recommending it for marketing authorization to treat polymyalgia rheumatica (PMR).
- Novartis to pay $125M for blood-brain barrier crossing platform$125M · With Sironax
- Novartis strengthens Tyrol as a business location with new investments in KufsteinNovartis has invested approximately 1.8 billion Euro in Austria over the past ten years, strengthening its sites in Kundl and Schaftenau.
- Novartis India Receives Detailed Public Statement for ₹552.49 Crore Open OfferNovartis AG has agreed to sell its 70.68% stake in Novartis India Limited to a consortium led by WaveRise Investments Limited for a total consideration of ₹1,445.89 crore.
- Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1)Novartis is planning to meet with the FDA to discuss next steps for its delpacibart braxlosiran (del-brax) therapy for facioscapulohumeral muscular dystrophy (FSHD).
- Novartis continues to cut jobs in SwitzerlandNovartis plans to move part of its biologics production activities from Kleinbasel to its campus in Basel by the end of 2027.
- Innexis Acquires Novartis's Kundl SiteWith Innexis Group
- Novartis: towards a reduction of 130 positions in BaselNovartis plans to transform its Rhine campus into a center for biological treatments by moving laboratories there by the end of 2028.
Showing 10 of 30 dated events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Novartis with the Signal API
One POST /v1/companies/enrich call with novartis.com returns Novartis news signals (news), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"novartis.com","signal_types":["news"],"limit":20}'Same industry
News at related companies
Questions about Novartis news
What is the latest news on Novartis?
What is going on with Novartis?
Is Novartis laying off employees?
Source. News articles about the company, one source link per event.
Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.
Data as of .